Search results
Heather Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn.
- 4
- Heather Kirby
- Businesswoman
- West Virginia University (BA)
Sep 7, 2021 · Heather Bresch, the former president and CEO of Mylan, worked with Pfizer to corner the market and keep prices of the EpiPen high, according to new documents released as part of an ongoing lawsuit. The documents also show Bresch approving a scheme to force customers to purchase two EpiPens at once, regardless of medical need.
- Ryan Grim
Jul 29, 2019 · Bresch has led Mylan since 2012, overseeing its growth from a generics company to a global pharmaceutical giant. She will step down in mid-2020, after the deal with Pfizer's Upjohn business, following years of controversies and investigations.
- Eric Sagonowsky
Mar 17, 2022 · Heather Bresch, the former CEO of Mylan and the daughter of Sen. Joe Manchin, D-W.Va., was accused of inflating the price of EpiPens and facing legal consequences. The settlement of a federal antitrust case means she will avoid trial and keep her job as a West Virginia University president.
Jan 27, 2017 · In her first in-depth interview since testifying on Capitol Hill, Bresch defends Mylan's investment in EpiPen and blames the system for high drug prices. She says she agrees with President Trump's demand for change and wants to work with employers, patients and the administration to fix the problem.
- 7 min
Aug 24, 2016 · Heather Bresch's career has risen along with her father's, a fact that has not gone unnoticed by her critics. But Bresch's corporate rise is also a modern-day success story.
People also ask
Who is Heather Bresch?
What happened to Mylan CEO Heather Bresch?
How much money does Heather Bresch make a year?
How much money will Bresch collect with a change in leadership?
Heather Bresch is the chief executive officer of Mylan, a global generics and specialty pharmaceutical company. She has advocated for access to medicine, especially for HIV/AIDS, biologics and food allergies, and has led several acquisitions and policy changes at Mylan.
